CHARACTERISTICS OF OUTPATIENTS INITIATED ON OLANZAPINE VERSUS RISPERIDONE IN THE TREATMENT OF SCHIZOPHRENIA IN JAPAN

被引：0
|
作者：
Ye, W. [1 ]
Nakahara, N. [1 ]
Takahashi, M. [1 ]
Ascher-Svanum, H. [2 ]
机构：
[1] Eli Lilly Japan KK, Kobe, Hyogo, Japan
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
VALUE IN HEALTH | 2010年 / 13卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(11)73322-8
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A554 / A554
页数：1
相关论文
共 50 条
  • [21] Olanzapine, risperidone and haloperidol in the treatment of adolescent patients with schizophrenia
    D. Gothelf
    A. Apter
    J. Reidman
    A. Brand-Gothelf
    Y. Bloch
    G. Gal
    L. Kikinzon
    S. Tyano
    R. Weizman
    G. Ratzoni
    [J]. Journal of Neural Transmission, 2003, 110 : 545 - 560
  • [22] A comparative effectiveness study of risperidone and olanzapine in the treatment of schizophrenia
    Ho, BC
    Miller, D
    Nopoulos, P
    Andreasen, NC
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 1999, 60 (10) : 658 - 663
  • [23] Reducing violence risk in persons with schizophrenia: Olanzapine versus risperidone
    Swanson, JW
    Swartz, MS
    Elbogen, EB
    Van Dorn, RA
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2004, 65 (12) : 1666 - 1673
  • [24] Olanzapine, risperidone and haloperidol in the treatment of adolescent patients with schizophrenia
    Gothelf, D
    Apter, A
    Reidman, J
    Brand-Gothelf, A
    Bloch, Y
    Gal, G
    Kikinzon, L
    Tyano, S
    Weizman, R
    Ratzoni, G
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2003, 110 (05) : 545 - 560
  • [25] Safety and tolerability of olanzapine versus risperidone:: a one-year randomized study in outpatients with schizophrenia with prominent negative symptoms
    Ciudad, A.
    Alvarez, E.
    Bousono, M.
    Olivares, J. M.
    Gomez, J. C.
    [J]. ACTAS ESPANOLAS DE PSIQUIATRIA, 2007, 35 (02): : 105 - 114
  • [26] Subjective response to clozapine and risperidone treatment in outpatients with schizophrenia
    Kim, JH
    Kim, SY
    Ahn, YM
    Kim, YS
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2006, 30 (02): : 301 - 305
  • [27] Effectiveness and safety of olanzapine in the treatment of Asian outpatients with schizophrenia
    Budiman, R
    Gondoyoewono, H
    Chaudhry, HR
    Hashmi, IT
    Habil, MH
    Rahman, AHBA
    Samanwongthai, U
    Levitt, L
    Becker, S
    Buenaventura, R
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S264 - S265
  • [28] Effectiveness and safety of olanzapine in the treatment of Asian outpatients with schizophrenia
    Habil, M. H.
    Gondoyoewono, H.
    Chaudhry, H. R.
    Samanwongthai, U.
    Hamid, A. R. A.
    Hashmi, I. T.
    Budiman, R.
    Knowles, A. G.
    Buenaventura, R.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2007, 45 (12) : 631 - 642
  • [29] Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders
    Tran, PV
    Hamilton, SH
    Kuntz, AJ
    Potvin, JH
    Andersen, SW
    Beasley, C
    Tollefson, GD
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1997, 17 (05) : 407 - 418
  • [30] A comparison of olanzapine versus risperidone for the treatment of schizophrenia: a meta-analysis of randomised clinical trials
    Mudge, MAC
    Davey, PJ
    Coleman, KA
    Montgomery, W
    Croker, VS
    Mullen, K
    Castle, DJ
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2005, 9 (01) : 3 - 15
12345